Financial results 2023

of net sales were international

A stronger international presence

with our main subsidiaries based in China, Germany, Spain and Italy accounting for a cumulated revenue of more than €700M. Our 5 other priority regions — the US, Mexico, Brazil, Benelux and Poland — achieved a growth of 17%. Our objective of generating over €500M by 2025.

High-growth activities

Dermo-Cosmetics & Personal Care (DC&PC) generated net sales of €1,60M, 57% of total revenue, a 9.9% growth on a constant scope and exchange rate basis.

Eau Thermale Avène obtained revenue above the symbolic €1bn threshold, reaffirming its ranking as the world’s No. 2 dermo-cosmetics brand. Ducray, A-Derma, Darrow and Pierre Fabre Oral Care also posted significant growth.

Medical Care generated net sales of €1,174 million, 42% of the company’s total revenue, up 4% compared to 2022 on a constant scope and exchange rate basis.

The growth of Innovative Oncology was driven by three targeted therapies for the treatment of cancers with specific mutations (melanoma, colorectal cancer and breast cancer). This past year also marked the launch of the world's first allogeneic T-cell immunotherapy available in Europe, for the treatment of a rare lymphoproliferative disorder.

+12 %

increase in the R&D budget

200 M€

in acquisitions

Innovation as a driving force

We have invested heavily in innovation. On the one hand, our research and development budget rose by 12% to €190M. On the other, we signed several partnerships and/or acquisitions for a total investment of more than €200M

Partnership with Scorpion Therapeutics for the co-development of active ingredients STX-721 and STX-241 and the acquisition of a license to market them in Europe and China (treatment for non- small cell lung cancer).

Acquisition of Vertical Bio and its drug candidate VERT- 002 (e.g., of non-small cell lung cancer).

Expansion of licensing rights for EBVALLO^® (tabelecleucel) to all territories worldwide (treatment of a rare lymphoproliferative disorder).

Acquisition of MÊME Cosmetics, the first-ever brand of dermo-cosmetic care products to alleviate the adverse effects of cancer treatments.

Read also

Illustration de deux personnes de différentes générations travaillent ensemble sur des ordinateurs portables, représentant la collaboration intergénérationnelle.

Caring for employees

Leveraging generational diversity to drive business growth.

Personnes travaillant sur des ordinateurs dans un bureau moderne.

Caring for our ecosystem

Sustainable development is a core commitment of Green Mission Pierre Fabre.

Un employé portant une charlotte bleue et des lunettes de sécurité, tenant un produit dans l'usine de Soual, entouré de machines industrielles.

Investing in industrial decarbonization

Every year, Pierre Fabre further reduces the environmental impact of its activities, as it seeks to embody a more sober, virtuous industrial model. In 2023, the company’s efforts led to two-figure reductions in energy and water consumption.

Deux femmes souriantes, l'une portant un pull vert et des lunettes, l'autre portant un sweat-shirt rouge, formant un cœur avec leurs mains devant un mur de briques.

Caring for our local communities

Caring for our local communities means supporting local stakeholders and associations. In the field of sport or charity work, for example.

llustration de 3 scientifiques, avec des fleurs et un ordinateur

Asessing, anticipating and controlling risks

The Pierre Fabre S.A. Supervisory Board, the Audit Committee, the strategic committee whose members come from the Supervisory Board and the the Executive Committee.

Tableau représentant Pierre Fabre exposé lors de la cérémonie.

Pierre Fabre, a sharing mindset

On July 20, 2023, to commemorate the 10-year anniversary of the passing of Mr. Pierre Fabre, a ceremony attended by 500 guests was held at the Domaine d’En Doyse.